Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Theranostics
; 10(12): 5384-5397, 2020.
Article
in En
| MEDLINE
| ID: mdl-32373219
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Carcinoma, Hepatocellular
/
Sorafenib
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Theranostics
Year:
2020
Type:
Article
Affiliation country:
China